Subtopic Deep Dive

Methicillin-Resistant Staphylococcus aureus (MRSA)
Research Guide

What is Methicillin-Resistant Staphylococcus aureus (MRSA)?

Methicillin-Resistant Staphylococcus aureus (MRSA) is a pathogenic strain of S. aureus that resists methicillin and other beta-lactam antibiotics due to the mecA gene.

MRSA causes severe infections in healthcare and community settings, including skin/soft-tissue infections, bacteremia, and endocarditis. Key guidelines from IDSA (Liu et al., 2011, 4076 citations) provide evidence-based treatments like vancomycin and daptomycin. Over 10 high-citation papers since 2003 document its epidemiology and management.

15
Curated Papers
3
Key Challenges

Why It Matters

MRSA drives global morbidity, with emergency department skin infections primarily caused by MRSA across 11 U.S. cities (Moran et al., 2006, 2290 citations). IDSA guidelines (Liu et al., 2011) recommend empiric therapy adjustments, reducing treatment failures in adults and children. Antimicrobial stewardship programs (Dellit et al., 2006, 3309 citations) curb MRSA spread via optimized dosing, impacting hospital infection rates. Catheter-related prevention (O’Grady et al., 2011, 4588 citations) lowers MRSA bloodstream infections.

Key Research Challenges

Evolving Treatment Resistance

MRSA strains develop resistance to vancomycin and linezolid, complicating therapy choices. Liu et al. (2011) guidelines highlight daptomycin dosing for bacteremia but note failures. Turner et al. (2019) review basic mechanisms driving multi-drug resistance.

Community Transmission Dynamics

CA-MRSA with Panton-Valentine leukocidin spreads rapidly worldwide (Vandenesch et al., 2003, 1696 citations). Moran et al. (2006) report MRSA as top emergency SSTI cause. Surveillance gaps hinder control in non-hospital settings.

Infection Control in Hospitals

Catheter-related MRSA infections persist despite guidelines (O’Grady et al., 2011). Stewardship implementation varies (Dellit et al., 2006). Endocarditis management requires multimodal approaches (Habib et al., 2015, 4864 citations).

Essential Papers

1.

2015 ESC Guidelines for the management of infective endocarditis

Gilbert Habib, Patrizio Lancellotti, Manuel J. Antunes et al. · 2015 · European Heart Journal · 4.9K citations

Guidelines for the management of infective endocarditis

2.

Guidelines for the Prevention of Intravascular Catheter-related Infections

Naomi P. O’Grady, Mary Alexander, Lillian A. Burns et al. · 2011 · Clinical Infectious Diseases · 4.6K citations

Although many catheter-related bloodstream infections (CR-BSIs) are preventable, measures to reduce these infections are not uniformly implemented.To update an existing evidenced-based guideline th...

3.

Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children

Catherine Liu, Arnold S. Bayer, Sara E. Cosgrove et al. · 2011 · Clinical Infectious Diseases · 4.1K citations

Abstract Evidence-based guidelines for the management of patients with methicillin-resistant Staphylococcus aureus (MRSA) infections were prepared by an Expert Panel of the Infectious Diseases Soci...

4.

Antibacterial resistance worldwide: causes, challenges and responses

Stuart B. Levy, Bonnie Marshall · 2004 · Nature Medicine · 4.0K citations

5.

Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America Guidelines for Developing an Institutional Program to Enhance Antimicrobial Stewardship

Timothy H. Dellit, Robert C. Owens, John E. McGowan et al. · 2006 · Clinical Infectious Diseases · 3.3K citations

This document presents guidelines for developing institutional programs to enhance antimicrobial stewardship, an activity that includes appropriate selection, dosing, route, and duration of antimic...

6.

Methicillin-Resistant <i>S. aureus</i> Infections among Patients in the Emergency Department

Gregory J. Moran, Anusha Krishnadasan, Rachel Gorwitz et al. · 2006 · New England Journal of Medicine · 2.3K citations

MRSA is the most common identifiable cause of skin and soft-tissue infections among patients presenting to emergency departments in 11 U.S. cities. When antimicrobial therapy is indicated for the t...

Reading Guide

Foundational Papers

Start with Liu et al. (2011, 4076 citations) for core treatment guidelines, O’Grady et al. (2011, 4588 citations) for prevention, and Levy & Marshall (2004, 4006 citations) for resistance context.

Recent Advances

Turner et al. (2019, 1896 citations) for research overview; Habib et al. (2015, 4864 citations) for endocarditis updates.

Core Methods

mecA gene detection, PFGE typing for epidemiology, antimicrobial susceptibility testing per CLSI, and stewardship metrics (MIC, AUC/MIC ratios).

How PapersFlow Helps You Research Methicillin-Resistant Staphylococcus aureus (MRSA)

Discover & Search

Research Agent uses searchPapers and exaSearch to find MRSA guidelines like Liu et al. (2011, 4076 citations), then citationGraph reveals connected stewardship papers (Dellit et al., 2006) and findSimilarPapers uncovers CA-MRSA epidemiology (Moran et al., 2006).

Analyze & Verify

Analysis Agent applies readPaperContent to extract dosing protocols from Liu et al. (2011), verifies claims with CoVe against O’Grady et al. (2011), and runs PythonAnalysis on citation data for GRADE scoring of evidence strength in endocarditis guidelines (Habib et al., 2015).

Synthesize & Write

Synthesis Agent detects gaps in CA-MRSA treatments post-Liu et al. (2011), flags contradictions between community (Vandenesch et al., 2003) and hospital strains; Writing Agent uses latexEditText, latexSyncCitations for guidelines review, and latexCompile for publication-ready reports with exportMermaid transmission diagrams.

Use Cases

"Analyze MRSA bacteremia treatment failure rates from IDSA guidelines using statistics."

Research Agent → searchPapers('MRSA bacteremia IDSA') → Analysis Agent → readPaperContent(Liu 2011) → runPythonAnalysis(pandas on outcomes data) → statistical summary with GRADE scores.

"Draft a LaTeX review on MRSA catheter prevention strategies."

Synthesis Agent → gap detection(Liu 2011 + O’Grady 2011) → Writing Agent → latexEditText(structured sections) → latexSyncCitations(10 papers) → latexCompile → PDF with synced references.

"Find open-source code for MRSA genomic surveillance from recent papers."

Research Agent → searchPapers('MRSA genomics code') → Code Discovery → paperExtractUrls(Turner 2019) → paperFindGithubRepo → githubRepoInspect → validated analysis scripts.

Automated Workflows

Deep Research workflow conducts systematic review of 50+ MRSA papers, chaining searchPapers → citationGraph → DeepScan for 7-step verification of guidelines (Liu et al., 2011). Theorizer generates hypotheses on CA-MRSA evolution from Vandenesch et al. (2003) and Moran et al. (2006), using CoVe checkpoints. DeepScan analyzes resistance trends with runPythonAnalysis on multi-paper datasets.

Frequently Asked Questions

What defines MRSA?

MRSA is S. aureus resistant to methicillin via mecA gene, causing SSTIs, bacteremia, and endocarditis (Turner et al., 2019).

What are standard MRSA treatment methods?

IDSA guidelines (Liu et al., 2011) recommend vancomycin for SSTIs, daptomycin for bacteremia, with decolonization using mupirocin.

What are key MRSA papers?

Liu et al. (2011, 4076 citations) for treatments; O’Grady et al. (2011, 4588 citations) for prevention; Moran et al. (2006, 2290 citations) for emergency SSTIs.

What open problems exist in MRSA research?

Vancomycin resistance emergence, CA-MRSA global tracking, and stewardship gaps in low-resource settings (Levy & Marshall, 2004; Vandenesch et al., 2003).

Research Antimicrobial Resistance in Staphylococcus with AI

PapersFlow provides specialized AI tools for your field researchers. Here are the most relevant for this topic:

Start Researching Methicillin-Resistant Staphylococcus aureus (MRSA) with AI

Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.